Quick Takeaways
- RA CAPITAL MANAGEMENT, L.P. filed SCHEDULE 13D/A for EVOMMUNE, INC. Common Stock, $0.0001 par value per share (EVMN).
- Disclosed ownership: 9.7%.
- Date of event: 12 Feb 2026.
Quoteable Key Fact
"RA CAPITAL MANAGEMENT, L.P. disclosed 9.7% ownership in EVOMMUNE, INC. Common Stock, $0.0001 par value per share (EVMN) on 12 Feb 2026."
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original Filing| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| RA Capital Management, L.P. | 9.7% | 3,494,638 | 0 | 3,494,638 | /s/ Peter Kolchinsky | By Peter Kolchinsky, Authorized Signatory | 0001346824 |
| Peter Kolchinsky | 9.7% | 3,494,638 | 0 | 3,494,638 | /s/ Peter Kolchinsky | Peter Kolchinsky | 0001384859 |
| Rajeev Shah | 9.7% | 3,494,638 | 0 | 3,494,638 | /s/ Rajeev Shah | Rajeev Shah | 0001619841 |
| RA Capital Healthcare Fund, L.P. | 7.5% | 2,710,293 | 0 | 2,710,293 | /s/ Peter Kolchinsky | By RA Capital Healthcare Fund GP, LLC, its General Partner, By Peter Kolchinsky, Manager | 0001315082 |